Form 8-K ARS Pharmaceuticals, For: Jul 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Richard Lowenthal resigns from ARS Pharmaceuticals board
July 17, 2026 4:05 PM EDTRichard Lowenthal resigned from the board of directors of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) on July 15, 2026, effective immediately.
According to a company statement, Lowenthal's resignation was a condition of his right to receive severance compensation under the terms of his employment agreement... More
